BeOne Medicines Ltd. SVP & General Counsel Sells $418K in ADSs Under Rule 10b5-1 Plan

Insider Transaction Overview

On September 30, 2026, Lee Chan Henry, Senior Vice President and General Counsel of BeOne Medicines Ltd. (ONC), executed an open-market sale of 1,115 American Depositary Shares (ADSs) at an average price of $375.00 per share, totaling approximately $418,125.

Transaction Details

• Security: American Depositary Shares (each representing 13 Ordinary Shares)
• Transaction Code: S (Open-market sale)
• Shares Sold: 1,115 ADSs
• Price per Share: $375.00
• Aggregate Proceeds: $418,125.00
• Post-Transaction ADS Holdings: 0 ADSs
• Retained Direct Holdings: 311,324 Ordinary Shares (which includes 507 shares acquired via the Employee Share Purchase Plan)

Plan and Governance Context

• Rule 10b5-1 Plan: The transaction was executed under a pre-established Rule 10b5-1 trading plan adopted on May 29, 2026, indicating routine scheduled diversification rather than opportunistic trading based on material non-public information.
• Significance: Rated Low. The dollar volume ($418K) is relatively modest in context, and the insider continues to retain a substantial equity interest in the issuer via 311,324 directly held Ordinary Shares.